Asset Details
Do you wish to reserve the book?
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
Do you wish to request the book?
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
2019
Overview
Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non-medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory-access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.
Publisher
Wiley Periodicals, Inc,Wiley Periodicals Inc
Subject
/ Adult
/ Cannabis
/ Cocaine
/ Drugs
/ Heroin
/ Humans
/ Opioids
/ Prescription Drug Diversion - prevention & control
/ Prescription Drug Misuse - prevention & control
/ prescription drug monitoring programs
/ Prescription Drug Monitoring Programs - statistics & numerical data
/ Rx drugs
